Fidson Healthcare, in its unaudited financial books, recorded its highest half-year revenue and profit in five years despite a surge in input cost.
The pharmaceutical company recorded N20.4 billion as its revenue in half-year 2022, 58 percent increase from N12.9 billion in half-year 2021.
Fids
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```
Folake Balogun
Folake Balogun is a tech journalist covering Africa’s fast-growing digital economy with a strong focus on incisive analysis of startup trends, venture capital, and fintech innovation, while also exploring emerging technologies such as artificial intelligence and the future of connectivity by highlighting their economic and social impact.
